Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Martini

Showing results (421-430 of 548) with videos related to

Pageof 55
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|July 11, 2020
Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis With and Without Fever at Baseline: Results From an Open-Label, Active-Treatment Extension StudyHermine I Brunner, Pierre Quartier, Ekaterina Alexeeva, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 31, 2025
Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient-Reported Outcomes in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal TrialHermine I Brunner, Ekaterina Alexeeva, Marcia Bandeira, et al.
The Journal of Urology|May 25, 2021
Oncologic Surveillance for Variant Histology Bladder Cancer after Radical CystectomyAlberto Martini, Luca Afferi, Stefania Zamboni, et al.
Annals of the Rheumatic Diseases|August 12, 2022
Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trialHermine I Brunner, Ivan Foeldvari, Ekaterina Alexeeva, et al.
Journal of the American Society of Nephrology : JASN|November 16, 2014
Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted AntigensMaurizio Bruschi, Maricla Galetti, Renato Alberto Sinico, et al.
Arthritis and Rheumatism|February 5, 2005
A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety resultsNicolino Ruperto, Irina Nikishina, Evgueni D Pachanov, et al.
Cell Reports|June 18, 2013
Dependence of immunoglobulin class switch recombination in B cells on vesicular release of ATP and CD73 ectonucleotidase activityFrancesca Schena, Stefano Volpi, Caterina Elisa Faliti, et al.
Annals of the Rheumatic Diseases|March 2, 2012
An international registry on autoinflammatory diseases: the Eurofever experienceNatasa Toplak, Joost Frenkel, Seza Ozen, et al.
Annals of the Rheumatic Diseases|June 28, 2012
The PRINTO criteria for clinically inactive disease in juvenile dermatomyositisDragana Lazarevic, Angela Pistorio, Elena Palmisani, et al.
Annals of the Rheumatic Diseases|March 7, 2013
Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in childrenSeza Ozen, Erkan Demirkaya, Gayane Amaryan, et al.
Pageof 55

Showing results (421-430 of 548) with videos related to

Sort By:
Pageof 55
Arthritis & Rheumatology (Hoboken, N.J.)|July 11, 2020
Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis With and Without Fever at Baseline: Results From an Open-Label, Active-Treatment Extension StudyHermine I Brunner, Pierre Quartier, Ekaterina Alexeeva, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 31, 2025
Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient-Reported Outcomes in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal TrialHermine I Brunner, Ekaterina Alexeeva, Marcia Bandeira, et al.
The Journal of Urology|May 25, 2021
Oncologic Surveillance for Variant Histology Bladder Cancer after Radical CystectomyAlberto Martini, Luca Afferi, Stefania Zamboni, et al.
Annals of the Rheumatic Diseases|August 12, 2022
Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trialHermine I Brunner, Ivan Foeldvari, Ekaterina Alexeeva, et al.
Journal of the American Society of Nephrology : JASN|November 16, 2014
Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted AntigensMaurizio Bruschi, Maricla Galetti, Renato Alberto Sinico, et al.
Arthritis and Rheumatism|February 5, 2005
A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety resultsNicolino Ruperto, Irina Nikishina, Evgueni D Pachanov, et al.
Cell Reports|June 18, 2013
Dependence of immunoglobulin class switch recombination in B cells on vesicular release of ATP and CD73 ectonucleotidase activityFrancesca Schena, Stefano Volpi, Caterina Elisa Faliti, et al.
Annals of the Rheumatic Diseases|March 2, 2012
An international registry on autoinflammatory diseases: the Eurofever experienceNatasa Toplak, Joost Frenkel, Seza Ozen, et al.
Annals of the Rheumatic Diseases|June 28, 2012
The PRINTO criteria for clinically inactive disease in juvenile dermatomyositisDragana Lazarevic, Angela Pistorio, Elena Palmisani, et al.
Annals of the Rheumatic Diseases|March 7, 2013
Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in childrenSeza Ozen, Erkan Demirkaya, Gayane Amaryan, et al.
Pageof 55